UNITY BIOTECHNOLOGY, INC.
UBX US91381U2006
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-74% | -84% | -35% | -49% | 12% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Ghosh Anirvan CEO |
1.03 USD |
96,797 Sold |
99,701 USD |
02/04/2025 | 02/04/2025 |
Sullivan Lynne Marie CFO |
1.03 USD |
21,867 Sold |
22,523 USD |
02/04/2025 | 02/04/2025 |
Nguyen Alexander Hieu CLO |
1.03 USD |
17,852 Sold |
18,388 USD |
02/04/2025 | 02/04/2025 |
Nguyen Alexander Hieu CLO |
1.16 USD |
1,954 Sold |
2,267 USD |
27/03/2025 | 27/03/2025 |
Nguyen Alexander Hieu CLO |
2.23 USD |
164 Sold |
366 USD |
04/02/2025 | 04/02/2025 |
Sullivan Lynne Marie CFO |
2.23 USD |
153 Sold |
341 USD |
04/02/2025 | 04/02/2025 |
Ghosh Anirvan CEO |
2.23 USD |
642 Sold |
1,432 USD |
04/02/2025 | 04/02/2025 |
Ghosh Anirvan CEO |
1.29 USD |
432 Sold |
557 USD |
04/11/2024 | 04/11/2024 |
Sullivan Lynne Marie CFO |
1.29 USD |
136 Sold |
175 USD |
04/11/2024 | 04/11/2024 |
Nguyen Alexander Hieu CLO |
1.29 USD |
149 Sold |
192 USD |
04/11/2024 | 04/11/2024 |